Literature DB >> 3515681

Clinical management of immunosuppressive therapy for cyclosporine-treated recipients of cadaver kidney transplants at one to six months.

N J Feduska, J Melzer, W J Amend, F Vincenti, S Tomlanovich, O Salvatierra.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1986        PMID： 3515681

Source DB:  PubMed          Journal:  Transplant Proc        ISSN： 0041-1345            Impact factor:   1.066


× No keyword cloud information.
  4 in total

1.  Evolution of hepatitis B virus liver disease after hepatic replacement. Practical and theoretical considerations.

Authors:  A J Demetris; S Todo; D H Van Thiel; J J Fung; Y Iwaki; G Sysyn; W Ming; J Trager; T E Starzl
Journal:  Am J Pathol       Date:  1990-09       Impact factor: 4.307

2.  Beta-2-microglobulin expression in the liver after liver transplantation.

Authors:  S G Hubscher; D H Adams; E Elias
Journal:  J Clin Pathol       Date:  1988-10       Impact factor: 3.411

3.  Post-transplant recurrent hepatitis B viral liver disease. Viral-burden, steatoviral, and fibroviral hepatitis B.

Authors:  M J Phillips; R Cameron; M A Flowers; L M Blendis; P D Greig; I Wanless; M Sherman; R Superina; B Langer; G A Levy
Journal:  Am J Pathol       Date:  1992-06       Impact factor: 4.307

4.  Massive haemorrhagic necrosis of the liver after liver transplantation.

Authors:  S G Hübscher; D H Adams; J A Buckels; P McMaster; J Neuberger; E Elias
Journal:  J Clin Pathol       Date:  1989-04       Impact factor: 3.411
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.